BrainStorm Expands Collaboration With Rutgers for Spinal Cord Injuries

BrainStorm Cell Therapeutics has expanded its collaboration with Rutgers University in an effort to cure spinal cord injuries through BrainStorm’s cutting-edge adult stem cell research.

The Spinal Cord Injury Project is the first focus of the W M Keck Center for Collaborative Neuroscience at Rutgers University. The study, combined with BrainStorm’s unique differentiation process, uses stem cells derived from human bone marrow that are expanded and induced to secrete neurotrophic factors. Preliminary evidence has indicated that transplantation of differentiated (but not non-differentiated) human bone marrow derived stem cells improved motor behavior of subjects used in animal studies as measured by motor and walking analysis.

Chaim Lebovits, president of BrainStorm Cell Therapeutics, said: “Our preliminary results provide a strong validation for continuing our collaborative efforts to confirm these findings through additional testing that could, with G-D’s help, potentially lead to a new strategy for cell therapy to cure spinal cord injuries.”